Companies: 10,795·Total market cap: $144.5T

Standard BioTools Inc.

Standard BioTools Inc.

LABNASDAQHealthcare● Active

$1.15

$-0.12(-9.45%)

Market Cap$448923328

P/E Ratio—

52W High$1.72

52W Low$0.87

Avg Volume2.5M

Open$1.27

Beta1.38

股票排行：Medical - Devices·Healthcare·查看全部市值排行 →

Standard BioTools Inc.（LAB）股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · LAB · 截至 Jun 8, 2026

关键指标

EPS (TTM)$-0.25Earnings history

PE Ratio (TTM)—PE Ratio deep dive

Revenue (TTM)$86.3MFull revenue history

Dividend Yield不分红Dividend history

Shares Outstanding381.6MShares outstanding history

Next EarningsAug 10, 2026Est.Earnings history

探索 Standard BioTools Inc. 数据

分析师预测$3 · Buy

股息不分红

营收$85.3M-51.08%

盈利EPS $-0.20+61.54%

财务快照

FY 2025Revenue$85.3M▼ 51.08% YoY

202320242025

FY 2025Net Income-$74.9M▲ +46.07% YoY

202320242025

FY 2025EPS$-0.20▲ +61.54% YoY

202320242025

TTM:Revenue: $86.3MNet Income: -$94.1MEPS: $-0.25View income statement →

分析师评级与目标价

Buy10 位分析师

Strong Buy

0

Buy

6

Hold

4

Sell

0

Strong Sell

0

12-Month Price Target

$3.25Low

$1.15Current

$3.25Avg Target上涨空间 182.61%

$3.25High

合计: 10 · 买入占比: 60.0%

根据过去 3 个月内 10 位华尔街分析师，LAB 共识评级为 Buy，12 个月平均目标价 $3.25 （较现价 $1.15 上涨空间 182.61%）。

竞争对手与同行

#TickerCompanyPriceChangeMkt Cap

Standard BioTools Inc.

$1.15-9.45%$448.9M #2

ADC Therapeutics S.A.

$1.03-21.97%$131.0M #3

Avanos Medical, Inc.

$25.05+0.20%$1.2B #4

$9.04+3.91%$612.4M #5

$18.25-2.67%$692.5M #6

Cullinan Therapeutics, Inc.

$13.51-6.38%$830.3M

股票表现

1D-9.45%

1W+0.88%

1M+12.75%

3M+16.14%

YTD-10.16%

1Y+6.48%

5Y-79.46%

关于 Standard BioTools Inc.

CEOMichael Egholm

IPO DateFeb 10, 2011

Employees814

CountryUS

Websitestandardbio.com

Standard BioTools Inc. together with its subsidiaries, develops, manufactures, and sells a range of instrumentation, consumables, and services to scientists and biomedical researchers to develop ther…

Medical - Devices HealthcareNASDAQUS

关于股票概览与关键数据

Standard BioTools Inc.（LAB）是 Medical - Devices 行业的 Healthcare 类公司，于 Feb 10, 2011 在 NASDAQ 上市。截至最近交易日，LAB 股价为 $1.15，市值约为 $448.9M。过去12个月累计回报 +6.48%，年初至今回报 -10.16%。

根据 10 位华尔街分析师，Standard BioTools Inc. 股票共识评级为Buy，12个月平均目标价为 $3.25。2025 财年 Standard BioTools Inc. 营收 $85.3M，净利润 -$74.9M。更多数据（营收历史、盈利、股息、市盈率）请使用上方标签页。

常见问题

截至最近一个交易日，Standard BioTools Inc.（LAB）股价为 $1.15，在 NASDAQ 上市，52周区间为 $0.87 – $1.72。

LAB 最新股价LAB quote todaylive ticker 实时行情

数据来源：Financial Modeling Prep最后更新：Jun 8, 2026本内容不构成投资建议